Breast cancer patients could be spared chemotherapy with new genetic test, study shows

By Kate Aubusson
Updated September 10 2016 - 11:08am, first published August 26 2016 - 9:26pm
A Mammaprint microarray showing the biopsy results of low risk (top) and high risk (bottom) breast cancer tumours. Photo: Supplied
A Mammaprint microarray showing the biopsy results of low risk (top) and high risk (bottom) breast cancer tumours. Photo: Supplied

It's a gruelling decision every breast cancer patient and their doctor must consider: do we need to start chemotherapy, or could we spare you the ravages of the toxic, yet potentially life-saving treatment?